Vir Bio (VIR) Revenue & Revenue Breakdown
Vir Bio Revenue Highlights
Latest Revenue (Y)
$68.56M
Latest Revenue (Q)
$238.95M
Main Segment (Y)
License And Collaboration Revenue
Main Geography (Y)
Non-US
Vir Bio Revenue by Period
Vir Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $68.56M | -7.61% |
| 2024-12-31 | $74.20M | -13.90% |
| 2023-12-31 | $86.18M | -94.67% |
| 2022-12-31 | $1.62B | 47.51% |
| 2021-12-31 | $1.10B | 1528.99% |
| 2020-12-31 | $67.25M | 9357.81% |
| 2019-12-31 | $711.00K | -18.09% |
| 2018-12-31 | $868.00K | 482.55% |
| 2017-12-31 | $149.00K | - |
Vir Bio generated $68.56M in revenue during NA 2025, up -7.61% compared to the previous quarter, and up 101.95% compared to the same period a year ago.
Vir Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $238.95M | -824051.72% |
| 2026-03-31 | $-29.00K | -100.05% |
| 2025-12-31 | $64.07M | 26595.83% |
| 2025-09-30 | $240.00K | -80.23% |
| 2025-06-30 | $1.21M | -59.96% |
| 2025-03-31 | $3.03M | -75.50% |
| 2024-12-31 | $12.37M | 419.92% |
| 2024-09-30 | $2.38M | -22.60% |
| 2024-06-30 | $3.08M | -94.55% |
| 2024-03-31 | $56.38M | 235.83% |
| 2023-12-31 | $16.79M | 536.11% |
| 2023-09-30 | $2.64M | -30.50% |
| 2023-06-30 | $3.80M | -93.97% |
| 2023-03-31 | $62.96M | 27.42% |
| 2022-12-31 | $49.41M | -86.81% |
| 2022-09-30 | $374.56M | -1021.90% |
| 2022-06-30 | $-40.63M | -103.30% |
| 2022-03-31 | $1.23B | 51.64% |
| 2021-12-31 | $812.75M | 684.38% |
| 2021-09-30 | $103.62M | -41.48% |
| 2021-06-30 | $177.07M | 29167.44% |
| 2021-03-31 | $605.00K | 101.00% |
| 2020-12-31 | $301.00K | 60.11% |
| 2020-09-30 | $188.00K | -99.72% |
| 2020-06-30 | $66.27M | 1058.95% |
| 2020-03-31 | $5.72M | 483.47% |
| 2019-12-31 | $980.00K | 313.50% |
| 2019-09-30 | $237.00K | 175.58% |
| 2019-06-30 | $86.00K | 405.88% |
| 2019-03-31 | $17.00K | 183.33% |
| 2018-12-31 | $6.00K | -94.74% |
| 2018-09-30 | $114.00K | -95.10% |
| 2018-06-30 | $2.33M | - |
| 2018-03-31 | $2.33M | - |
Vir Bio generated $238.95M in revenue during Q2 2026, up -824051.72% compared to the previous quarter, and up 7880.80% compared to the same period a year ago.
Vir Bio Revenue Breakdown
Vir Bio Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Other Revenue | $3.39M | - | - | - | - |
| License And Collaboration Revenue | $63.13M | - | - | - | - |
| Grant | $2.04M | $10.49M | $46.69M | - | - |
| Contract Revenue | - | $55.33M | $2.23M | $52.71M | $169.87M |
| Collaboration Revenue | - | $8.38M | $37.27M | $1.51B | $917.19M |
| License Revenue | - | - | - | - | - |
| License | - | - | - | $22.29M | - |
Vir Bio's latest annual revenue breakdown by segment (product or service), as of Dec 25: License And Collaboration Revenue (92.09%), Other Revenue (4.94%), and Grant (2.97%).
Quarterly Revenue by Product
| Product/Service | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grant | $11.00K | $12.00K | $310.00K | $305.00K | $183.00K | $1.24M | $1.10M | $2.09M | $2.13M | $5.17M | $23.43M | $6.74M | $16.52M | - | - | - | - | - | - | - |
| License And Collaboration Revenue | $238.94M | $-41.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Collaboration Revenue | - | - | - | $-65.00K | $-495.00K | $-70.00K | $8.32M | $55.00K | - | $-4.39M | $46.57M | $21.61M | $309.14M | $-54.94M | $1.23B | $809.46M | $102.40M | - | - | - |
| Contract Revenue | - | - | - | - | $1.53M | $1.86M | $865.00K | $1.39M | $886.00K | $52.19M | $744.00K | $289.00K | $1.06M | $138.00K | $180.00K | $40.00M | $12.25M | $282.00K | $293.00K | $315.00K |
| License Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $22.29M | - | - | - | - |
Vir Bio's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: License And Collaboration Revenue (100.00%), and Grant (0.00%).
Vir Bio Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 |
|---|---|---|
| UNITED STATES | $2.04M | $11.53M |
| Non-US | $64.27M | $60.31M |
Vir Bio's latest annual revenue breakdown by geography, as of Dec 25: Non-US (96.93%), and UNITED STATES (3.07%).
Quarterly Revenue by Country
| Country | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 |
|---|---|---|---|---|---|---|
| UNITED STATES | $239.28M | $12.00K | $310.00K | $305.00K | $183.00K | $1.24M |
| Non-US | $-341.00K | $-41.00K | $60.94M | $-65.00K | $1.53M | $1.86M |
Vir Bio's latest quarterly revenue breakdown by geography, as of Jun 26: UNITED STATES (100.14%), and Non-US (-0.14%).
Vir Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics | $263.50M | $99.31M |
| GERN | Geron | $183.88M | $57.48M |
| DNA | Ginkgo Bioworks | $170.16M | $20.16M |
| DAWN | Day One Biopharmaceuticals | $158.18M | $39.80M |
| VIR | Vir Bio | $68.56M | $238.95M |
| KURA | Kura Oncology | $67.48M | $20.87M |
| MRVI | Maravai LifeSciences | $49.87M | $51.44M |
| LENZ | LENZ Therapeutics | $19.09M | $5.49M |
| PRME | Prime Medicine | $4.63M | $1.15M |
| YDES | YD Bio Limited Ordinary Shares | $510.36K | - |
| REPL | Replimune Group | - | - |